FR2469926A1 - Fraction extraite de moelle osseuse soluble dans l'eau capable de reguler les reactions immunitaires d'un hote vis-a-vis des cellules ou d'un tissu allogeniques, compositions contenant cette fraction et procede pour preparer cette fraction - Google Patents

Fraction extraite de moelle osseuse soluble dans l'eau capable de reguler les reactions immunitaires d'un hote vis-a-vis des cellules ou d'un tissu allogeniques, compositions contenant cette fraction et procede pour preparer cette fraction

Info

Publication number
FR2469926A1
FR2469926A1 FR8024835A FR8024835A FR2469926A1 FR 2469926 A1 FR2469926 A1 FR 2469926A1 FR 8024835 A FR8024835 A FR 8024835A FR 8024835 A FR8024835 A FR 8024835A FR 2469926 A1 FR2469926 A1 FR 2469926A1
Authority
FR
France
Prior art keywords
fraction
preparing
bone marrow
water
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8024835A
Other languages
English (en)
French (fr)
Other versions
FR2469926B1 (enExample
Inventor
Walter Pierpaoli
Georges Maestroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CELL ENG AG
Original Assignee
CELL ENG AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CELL ENG AG filed Critical CELL ENG AG
Publication of FR2469926A1 publication Critical patent/FR2469926A1/fr
Application granted granted Critical
Publication of FR2469926B1 publication Critical patent/FR2469926B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8024835A 1979-11-22 1980-11-21 Fraction extraite de moelle osseuse soluble dans l'eau capable de reguler les reactions immunitaires d'un hote vis-a-vis des cellules ou d'un tissu allogeniques, compositions contenant cette fraction et procede pour preparer cette fraction Granted FR2469926A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7940392 1979-11-22

Publications (2)

Publication Number Publication Date
FR2469926A1 true FR2469926A1 (fr) 1981-05-29
FR2469926B1 FR2469926B1 (enExample) 1983-12-30

Family

ID=10509350

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8024835A Granted FR2469926A1 (fr) 1979-11-22 1980-11-21 Fraction extraite de moelle osseuse soluble dans l'eau capable de reguler les reactions immunitaires d'un hote vis-a-vis des cellules ou d'un tissu allogeniques, compositions contenant cette fraction et procede pour preparer cette fraction

Country Status (9)

Country Link
US (1) US4540574A (enExample)
JP (1) JPS56501525A (enExample)
AU (1) AU544136B2 (enExample)
CH (1) CH650154A5 (enExample)
DK (1) DK312081A (enExample)
FR (1) FR2469926A1 (enExample)
GB (1) GB2074864B (enExample)
SE (1) SE8104458L (enExample)
WO (1) WO1981001367A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002105A1 (fr) * 1992-07-21 1994-02-03 Nikolaenko Alexandr N Agent biologiquement actif ayant des proprietes d'immunomodulation, procede pour sa production et preparation pharmaceutique a base de cet agent
EP0673652A4 (en) * 1992-07-21 1996-07-03 Nikolaenko Alexandr N BIOLOGICALLY ACTIVE AGENT HAVING IMMUNOMODULATION PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATION THEREOF.

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569110B1 (fr) * 1984-08-17 1987-09-25 Ionescu Pantelimon Dumitru Sang animal et moelle osseuse animale decancerisants, transfusibles aux hommes, procede et appareil pour leur preparation
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
US5482924A (en) * 1991-05-06 1996-01-09 Centre National De La Recherche Proteinaceous compositions having an activity on erythropoiesis
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
RU2152219C1 (ru) * 1998-04-08 2000-07-10 Научно-Исследовательский Институт Трансплантологии И Искусственных Органов Пептиды, обладающие иммуностимулирующей активностью, способ их получения, лекарственный препарат на их основе спленопид и его применение
RU2232584C1 (ru) * 2003-02-27 2004-07-20 Гурьянов Сергей Алексеевич Способ получения миелопида

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1345565A (fr) * 1962-01-19 1963-12-13 Rolland Lab A Procédé pour l'obtention d'extraits totaux plus généralement orginaires de tissus viants
NL6405724A (enExample) * 1963-05-23 1964-11-24
GB1086689A (en) * 1964-12-01 1967-10-11 Alkliam Chemicals Ltd Pharmaceutically active extracts of bone marrow
US3526697A (en) * 1966-10-06 1970-09-01 Nevada Pharm Inc Therapeutic method
FR2112112B1 (enExample) * 1970-11-04 1974-09-20 Rusin Marina
US4136170A (en) * 1975-11-21 1979-01-23 Andre Thomas Method of extracting a hyperglycemic factor
DE2961660D1 (en) * 1978-05-03 1982-02-18 Yves Marie Frank Souron Wound-healing product extracted from animal bone marrow

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002105A1 (fr) * 1992-07-21 1994-02-03 Nikolaenko Alexandr N Agent biologiquement actif ayant des proprietes d'immunomodulation, procede pour sa production et preparation pharmaceutique a base de cet agent
EP0673652A4 (en) * 1992-07-21 1996-07-03 Nikolaenko Alexandr N BIOLOGICALLY ACTIVE AGENT HAVING IMMUNOMODULATION PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATION THEREOF.

Also Published As

Publication number Publication date
JPS56501525A (enExample) 1981-10-22
FR2469926B1 (enExample) 1983-12-30
SE8104458L (sv) 1981-07-20
GB2074864B (en) 1984-08-22
AU6486980A (en) 1981-06-03
DK312081A (da) 1981-07-13
WO1981001367A1 (fr) 1981-05-28
AU544136B2 (en) 1985-05-16
CH650154A5 (de) 1985-07-15
US4540574A (en) 1985-09-10
GB2074864A (en) 1981-11-11

Similar Documents

Publication Publication Date Title
Hauschka et al. The influence of collagen on the development of muscle clones.
EP0243494A1 (en) Supercritical fluid extraction of animal derived materials
FR2469926A1 (fr) Fraction extraite de moelle osseuse soluble dans l'eau capable de reguler les reactions immunitaires d'un hote vis-a-vis des cellules ou d'un tissu allogeniques, compositions contenant cette fraction et procede pour preparer cette fraction
KR900700118A (ko) 알로에 생성물의 제조방법
Clegg et al. Protein synthesis in Artemia salina embryos: II. Resumption of RNA and protein synthesis upon cessation of dormancy in the encysted gastrula
DE3882725T2 (de) Verfahren zur Trennung von bösartigen Zellen aus einer klinischen Probe.
EP1135531A4 (en) METHODS FOR THE INTRODUCTION OF HETEROLOGIC CELLS IN FISH
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
Kullander et al. Human ovarian tumours heterotransplanted to “nude” mice
EP0035102A1 (de) Aus gesunden weissen Blutkörperchen beziehungsweise Granulozyten isolierbares, das Wachstum beziehungsweise die Vermehrung von normalen und leukämischen myeloiden Zellen selektiv hemmendes Oligopeptid, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
AU550390B2 (en) Mitogens of leukocytes
DE19726255C2 (de) Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
JP3150835B2 (ja) リグナン配糖体およびリグナン類の製造法
DE3268622D1 (en) Chemorecruitins of leukocytes and inflamed tissues: a new class of natural leukopoietin proteins for chemorecruitment of specific leukocyte types from the bone marrow into blood circulation (leukocytosis and leftward shift reactions), process for their biotechnical preparation and pharmaceutical compositions
Sirenko et al. Influence of metabolites of certain algae on human and animal cell cultures
Boury-Esnault et al. Glycogen storage and transfer in primitive invertebrates: Demospongea and Actiniaria. In: Lévi, C. & Boury-Esnault, N.(eds) Biologie des Spongiaires. Sponge Biology.
EP0019167A2 (de) Arzneipräparat zur Behandlung von Carcinomen und Verfahren zu dessen Herstellung
KR102179155B1 (ko) 옥추출물을 이용한 골세포 분화 방법
KR20010089498A (ko) 표고버섯 균사체 추출물을 함유하는 ｌａｋ 활성스크리닝물질 및 이를 사용한 ｌａｋ 활성스크리닝법
DE2812343A1 (de) Immunostimulatorischer wirkstoff, verfahren zu seiner gewinnung und arzneimittel
EP0396402A3 (en) Cell growth activators
SU1067040A1 (ru) Способ получени ферментного препарата из поджелудочной железы убойных животных
DE19726244C2 (de) Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung
CH659256A5 (de) Verfahren zur herstellung einer substanz mit carcinostatischer und immunostimulierender aktivitaet.
Ohta et al. Neuronal Differentiation of Ewing's Sarcoma Induced by Cholera Toxin B and Bromodeoxyuridine—Establishment of Ewing's Sarcoma Cell Line and Histochemical Study—

Legal Events

Date Code Title Description
ST Notification of lapse